CRISPR genome editing therapy lowers blood fats in early trial
A single infusion of an experimental CRISPR/Cas9 genome editing therapy reduced triglyceride levels by an average of 63 percent in people with severely elevated blood fats...
A single infusion of an experimental CRISPR/Cas9 genome editing therapy reduced triglyceride levels by an average of 63 percent in people with severely elevated blood fats...
by Professor Caroline Wright and 1 others
Newborn genome screening could transform the early detection of genetic conditions, but incomplete penetrance could lead to overdiagnosis and overtreatment. Large-scale population studies are needed to understand the risks and help design effective screening programmes…
A gene therapy for Huntington's disease failed to show statistically significant slowing of disease progression after 48 months, according to newly released data...
Parental age and various procedures used during assisted reproductive technology have been linked to different patterns of mutational changes in the DNA of offspring...
The discovery of a new gene-targeting system used by viruses to fend off competitors gives a glimpse into the possible evolutionary origin of CRISPR, and may offer new opportunities for genome editing technologies...
Base editing can efficiently alter the DNA of human embryos, but it can also result in unintended genomic changes....
Scientists have obtained the most complete and accurate sequence of a human diploid reference genome to date, paving the way for advancements in personalised medicine...
A six-year-old girl has died following an experimental genome editing treatment, prompting an investigation into the clinical trial by the university involved...
by BioNews
Behind every scientific breakthrough is a story. Dr Oliver Bower, the lead author of a recent Nature study, describes how listening to people affected by genetic disease reshaped his research and his perspective on the future of genome editing...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.